BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 30567349)

  • 1. The Amino-Terminal Region of Hepatitis E Virus ORF1 Containing a Methyltransferase (Met) and a Papain-Like Cysteine Protease (PCP) Domain Counteracts Type I Interferon Response.
    Bagdassarian E; Doceul V; Pellerin M; Demange A; Meyer L; Jouvenet N; Pavio N
    Viruses; 2018 Dec; 10(12):. PubMed ID: 30567349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis E virus inhibits type I interferon induction by ORF1 products.
    Nan Y; Yu Y; Ma Z; Khattar SK; Fredericksen B; Zhang YJ
    J Virol; 2014 Oct; 88(20):11924-32. PubMed ID: 25100852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis E Virus Cysteine Protease Has Papain Like Properties Validated by
    Saraswat S; Chaudhary M; Sehgal D
    Front Cell Infect Microbiol; 2019; 9():478. PubMed ID: 32039053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of interferon-α signaling by hepatitis E virus.
    Dong C; Zafrullah M; Mixson-Hayden T; Dai X; Liang J; Meng J; Kamili S
    Hepatology; 2012 May; 55(5):1324-32. PubMed ID: 22183878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Methyltransferase-Like Domain of Chikungunya Virus nsP2 Inhibits the Interferon Response by Promoting the Nuclear Export of STAT1.
    Göertz GP; McNally KL; Robertson SJ; Best SM; Pijlman GP; Fros JJ
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RIG-I is a key antiviral interferon-stimulated gene against hepatitis E virus regardless of interferon production.
    Xu L; Wang W; Li Y; Zhou X; Yin Y; Wang Y; de Man RA; van der Laan LJW; Huang F; Kamar N; Peppelenbosch MP; Pan Q
    Hepatology; 2017 Jun; 65(6):1823-1839. PubMed ID: 28195391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IFN regulatory factor 1 restricts hepatitis E virus replication by activating STAT1 to induce antiviral IFN-stimulated genes.
    Xu L; Zhou X; Wang W; Wang Y; Yin Y; Laan LJ; Sprengers D; Metselaar HJ; Peppelenbosch MP; Pan Q
    FASEB J; 2016 Oct; 30(10):3352-3367. PubMed ID: 27328944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nipah and Hendra Virus Nucleoproteins Inhibit Nuclear Accumulation of Signal Transducer and Activator of Transcription 1 (STAT1) and STAT2 by Interfering with Their Complex Formation.
    Sugai A; Sato H; Takayama I; Yoneda M; Kai C
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28835499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug screening identified gemcitabine inhibiting hepatitis E virus by inducing interferon-like response via activation of STAT1 phosphorylation.
    Li Y; Li P; Li Y; Zhang R; Yu P; Ma Z; Kainov DE; de Man RA; Peppelenbosch MP; Pan Q
    Antiviral Res; 2020 Dec; 184():104967. PubMed ID: 33137361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of hepatitis E virus ORF1 gene supports a papain-like cysteine protease (PCP)-domain activity.
    Parvez MK
    Virus Res; 2013 Dec; 178(2):553-6. PubMed ID: 23978667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The U-Rich Untranslated Region of the Hepatitis E Virus Induces Differential Type I and Type III Interferon Responses in a Host Cell-Dependent Manner.
    Sooryanarain H; Heffron CL; Meng XJ
    mBio; 2020 Jan; 11(1):. PubMed ID: 31937650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First Crystal Structure of a Nonstructural Hepatitis E Viral Protein Identifies a Putative Novel Zinc-Binding Protein.
    Proudfoot A; Hyrina A; Holdorf M; Frank AO; Bussiere D
    J Virol; 2019 Jul; 93(13):. PubMed ID: 31019049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual modulation of type I interferon response by bluetongue virus.
    Doceul V; Chauveau E; Lara E; Bréard E; Sailleau C; Zientara S; Vitour D
    J Virol; 2014 Sep; 88(18):10792-802. PubMed ID: 25008919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and processing of the Hepatitis E virus ORF1 nonstructural polyprotein.
    Sehgal D; Thomas S; Chakraborty M; Jameel S
    Virol J; 2006 May; 3():38. PubMed ID: 16725054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.
    Plumlee CR; Lazaro CA; Fausto N; Polyak SJ
    Virol J; 2005 Dec; 2():89. PubMed ID: 16324217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular modeling and analysis of hepatitis E virus (HEV) papain-like cysteine protease.
    Parvez MK; Khan AA
    Virus Res; 2014 Jan; 179():220-4. PubMed ID: 24321124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HEV ORF3 downregulatesCD14 and CD64 to impair macrophages phagocytosis through inhibiting JAK/STAT pathway.
    Lei Q; Li L; Huang W; Qin B; Zhang S
    J Med Virol; 2019 Jun; 91(6):1112-1119. PubMed ID: 30636344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
    Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
    Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Porcine Deltacoronavirus nsp5 Antagonizes Type I Interferon Signaling by Cleaving STAT2.
    Zhu X; Wang D; Zhou J; Pan T; Chen J; Yang Y; Lv M; Ye X; Peng G; Fang L; Xiao S
    J Virol; 2017 May; 91(10):. PubMed ID: 28250121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MDA5 against enteric viruses through induction of interferon-like response partially via the JAK-STAT cascade.
    Li Y; Yu P; Qu C; Li P; Li Y; Ma Z; Wang W; de Man RA; Peppelenbosch MP; Pan Q
    Antiviral Res; 2020 Apr; 176():104743. PubMed ID: 32057771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.